Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 38.93B | 41.31B | 40.65B | 39.99B | 39.28B | 43.08B |
Gross Profit | 38.93B | 28.76B | 20.23B | 27.05B | 27.02B | 30.06B |
EBITDA | 12.60B | 12.35B | 10.34B | 13.54B | 22.53B | 13.82B |
Net Income | -2.38B | -49.00M | -892.00M | 2.01B | 8.14B | 1.58B |
Balance Sheet | ||||||
Total Assets | 94.37B | 100.50B | 104.32B | 109.64B | 109.21B | 105.05B |
Cash, Cash Equivalents and Short-Term Investments | 8.19B | 9.26B | 7.67B | 9.69B | 12.41B | 8.10B |
Total Debt | 7.55B | 45.02B | 44.12B | 8.68B | 8.07B | 5.29B |
Total Liabilities | 73.39B | 77.75B | 77.23B | 77.93B | 80.53B | 86.79B |
Stockholders Equity | 17.28B | 19.35B | 21.85B | 25.09B | 22.21B | 11.23B |
Cash Flow | ||||||
Free Cash Flow | 5.35B | 5.20B | 5.49B | 5.30B | 4.10B | 6.18B |
Operating Cash Flow | 10.84B | 10.99B | 11.65B | 10.81B | 10.27B | 13.20B |
Investing Cash Flow | -4.83B | -5.22B | -4.29B | -5.33B | 5.90B | -7.79B |
Financing Cash Flow | -4.49B | -4.67B | -7.19B | -7.92B | -12.99B | -5.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $35.16B | 29.75 | 9.95% | 3.67% | 3.12% | 3.14% | |
74 Outperform | $58.13B | 20.21 | 14.41% | 2.74% | -0.64% | 56.92% | |
74 Outperform | $20.20B | 13.99 | 17.71% | 6.43% | -5.13% | -5.90% | |
72 Outperform | $19.77B | 19.77 | 8.20% | 3.53% | -6.51% | -0.21% | |
66 Neutral | ¥503.10B | 16.55 | 1.07% | 2.17% | 6.46% | -14.78% | |
60 Neutral | $28.08B | 9.21 | -7.17% | 4.23% | 0.89% | -494.16% | |
60 Neutral | $31.64B | ― | -3.55% | 6.31% | -4.73% | -251.31% |